LXRX Financial Facts

Total revenues: 27.72M
Loss from operations: -34.93M
See Full Income Statement

Other long-term liabilities: 2.5M
Commitments and contingencies: 0
See Full Balance Sheet

Lexicon Pharmaceuticals, Inc. (LXRX) Earnings

  |   Expand Research on LXRX
Next EPS Date 10/30/26 *Est. EPS Growth Rate -800.0% *Last Qtr.
Average EPS % Beat Rate +36.4% Revenue Growth Rate +0.1% *Last Qtr.
Average % Move 1-Wk after EPS +12.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/6/26 Q226 -$0.07-$0.05 -$0.02$28.9M$4M N/A Details
5/7/26 Q126 $0.00-$0.04 +$0.04$21.1M$9.78M N/A Details
5/4/26 Q126 N/A-$0.04 N/A N/A$9.78M N/A N/A N/A
5/1/26 Q126 N/A-$0.04 N/A N/A$9.78M N/A N/A N/A
4/30/26 Q126 N/A-$0.04 N/A N/A$9.78M N/A N/A N/A
3/5/26 Q425 -$0.04-$0.07 +$0.03$5.5M$3.92M N/A Details
11/6/25 Q325 -$0.04-$0.07 +$0.03$14.1M$4.65M N/A Details
10/30/25 Q325 N/A-$0.07 N/A N/A$4.65M N/A N/A N/A